BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33893078)

  • 1. Profiling of Serum Extracellular Vesicles Reveals
    Muramatsu-Maekawa Y; Kawakami K; Fujita Y; Takai M; Kato D; Nakane K; Kato T; Tsuchiya T; Koie T; Miura Y; Ito M; Mizutani K
    Cancer Genomics Proteomics; 2021; 18(3):253-259. PubMed ID: 33893078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
    Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
    J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
    Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
    Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting
    Meng L; Xing Z; Guo Z; Qiu Y; Liu Z
    Aging (Albany NY); 2021 Mar; 13(7):9613-9626. PubMed ID: 33742606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
    Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
    Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma.
    Huang G; Li H; Wang J; Peng X; Liu K; Zhao L; Zhang C; Chen X; Lai Y; Ni L
    Pathol Res Pract; 2020 Nov; 216(11):153152. PubMed ID: 32823234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
    White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM
    Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.
    Fedorko M; Stanik M; Iliev R; Redova-Lojova M; Machackova T; Svoboda M; Pacik D; Dolezel J; Slaby O
    Int J Mol Sci; 2015 Sep; 16(10):23382-9. PubMed ID: 26426010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma.
    He J; He J; Min L; He Y; Guan H; Wang J; Peng X
    Int J Cancer; 2020 Feb; 146(4):1052-1063. PubMed ID: 31259424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
    Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
    Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma.
    Grange C; Brossa A; Bussolati B
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
    White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
    J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
    Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
    Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 17. Large-scale genome-wide screening of circulating microRNAs in clear cell renal cell carcinoma reveals specific signatures in late-stage disease.
    Chanudet E; Wozniak MB; Bouaoun L; Byrnes G; Mukeriya A; Zaridze D; Brennan P; Muller DC; Scelo G
    Int J Cancer; 2017 Nov; 141(9):1730-1740. PubMed ID: 28639257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney.
    Zaravinos A; Lambrou GI; Mourmouras N; Katafygiotis P; Papagregoriou G; Giannikou K; Delakas D; Deltas C
    PLoS One; 2014; 9(3):e91646. PubMed ID: 24621579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of serum extracellular vesicles expressing prostate-specific membrane antigen in urologic malignancies.
    Kawakami K; Fujita Y; Kato T; Horie K; Koie T; Umezawa K; Tsumoto H; Miura Y; Katagiri Y; Miyazaki T; Ohsawa I; Mizutani K; Ito M
    Sci Rep; 2021 Jul; 11(1):15000. PubMed ID: 34294841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.
    Slaby O; Jancovicova J; Lakomy R; Svoboda M; Poprach A; Fabian P; Kren L; Michalek J; Vyzula R
    J Exp Clin Cancer Res; 2010 Jul; 29(1):90. PubMed ID: 20609231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.